Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (11-20 of 655) with videos related to

Pageof 66
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1996
New promising anticancer agents in development: what comes next?J Verweij
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
The prognosis of prognostic factors in phase I clinical trialsJ Verweij
Parasitology|May 1, 2014
Application of PCR-based methods for diagnosis of intestinal parasitic infections in the clinical laboratoryJaco J Verweij
Expert Review of Molecular Diagnostics|August 23, 2021
Validation and maintaining laboratory developed molecular tests compliant with ISO15189 for diagnosis of intestinal parasitic infectionsJaco J Verweij
Nederlands Tijdschrift Voor Geneeskunde|April 17, 1993
[Vitamin A derivatives: potential prevention and therapy of solid tumors]J Verweij, G Stoter
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
Early mortality rates: a tool for phase III trials or for changing standard practice?J Verweij, J Smyth
Clinical Pharmacology and Therapeutics|January 20, 2009
Advances in cancer therapeuticsA Sparreboom, J Verweij
Seminars in Radiation Oncology|October 12, 1999
The reason for confining the use of adjuvant chemotherapy in soft tissue sarcoma to the investigational settingJ Verweij, C Seynaeve
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2007
Introduction to 'A multitargeted approach: clinical advances in the treatment of solid tumours'D George, J Verweij
The Netherlands Journal of Medicine|February 1, 1987
Severe side effects of the cytotoxic drug mitomycin-CJ Verweij, G Stoter
Pageof 66

Showing results (11-20 of 655) with videos related to

Sort By:
Pageof 66
Cancer Chemotherapy and Pharmacology|January 1, 1996
New promising anticancer agents in development: what comes next?J Verweij
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
The prognosis of prognostic factors in phase I clinical trialsJ Verweij
Parasitology|May 1, 2014
Application of PCR-based methods for diagnosis of intestinal parasitic infections in the clinical laboratoryJaco J Verweij
Expert Review of Molecular Diagnostics|August 23, 2021
Validation and maintaining laboratory developed molecular tests compliant with ISO15189 for diagnosis of intestinal parasitic infectionsJaco J Verweij
Nederlands Tijdschrift Voor Geneeskunde|April 17, 1993
[Vitamin A derivatives: potential prevention and therapy of solid tumors]J Verweij, G Stoter
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
Early mortality rates: a tool for phase III trials or for changing standard practice?J Verweij, J Smyth
Clinical Pharmacology and Therapeutics|January 20, 2009
Advances in cancer therapeuticsA Sparreboom, J Verweij
Seminars in Radiation Oncology|October 12, 1999
The reason for confining the use of adjuvant chemotherapy in soft tissue sarcoma to the investigational settingJ Verweij, C Seynaeve
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2007
Introduction to 'A multitargeted approach: clinical advances in the treatment of solid tumours'D George, J Verweij
The Netherlands Journal of Medicine|February 1, 1987
Severe side effects of the cytotoxic drug mitomycin-CJ Verweij, G Stoter
Pageof 66